Psychiatry and Neurology, Neurology · Union City, NJ
NPI
1710918115
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
727 1oth Street
Union City, NJ, 07087
Phone (201) 864-5252
Groups this clinician bills Medicare through
Medicare paid, 2024
$198K
2,047 services
Medicare patients, 2024
303
Average age 74
Drug cost, 2024
$7.2M
8,867 prescriptions
Company payments, 2025
$8,398
From 47 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nagesh B Krish was code 99214 (office e&m - established), 627 times for 264 patients. In total Nagesh B Krish billed 2,047 services in 39 codes, and Medicare paid $198K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 627 | 264 | $117.07 | $73K |
| 96372 Injection Administration | Office | 356 | 185 | $13.56 | $4,826 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 356 | 185 | $1.02 | $364 |
| 95886 Electrical Nerve Conductivity | Office | 87 | 44 | $92.15 | $8,017 |
| 95816 Neurologic | Office | 69 | 67 | $386.61 | $27K |
| 95911 Electrical Nerve Conductivity | Office | 47 | 44 | $200.56 | $9,426 |
| 99204 Office E&M - New | Office | 46 | 46 | $153.64 | $7,067 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 34 | 34 | $157.58 | $5,358 |
| 95700 Neurologic | Office | 25 | 25 | $219.93 | $5,498 |
| 93886 Ultrasound - Nonspecific | Office | 21 | 21 | $266.03 | $5,587 |
| 99213 Office E&M - Established | Office | 20 | 12 | $82.58 | $1,652 |
| 95712 Neurologic | Office | 18 | 18 | $439.84 | $7,917 |
| 95718 Neurologic | Office | 18 | 18 | $124.86 | $2,248 |
| 99215 Office E&M - Established | Office | 18 | 17 | $168.28 | $3,029 |
| 95810 Sleep Study | Office | 13 | 13 | $416.53 | $5,415 |
By year: 2022 $254K for 2,410 services; 2023 $243K for 2,427 services; 2024 $198K for 2,047 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nagesh B Krish prescribed most often to Medicare patients was Gabapentin, with 1,200 prescriptions and refills. In total Nagesh B Krish wrote 8,867 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,200 | 1,665 | 282 | $12K |
| Donepezil Hcl Generic | 642 | 1,343 | 172 | $5,653 |
| Memantine Hcl Generic | 514 | 1,019 | 129 | $16K |
| Levetiracetam Generic | 385 | 686 | 83 | $10K |
| Pregabalin Generic | 374 | 500 | 80 | $6,856 |
| Duloxetine Hcl Generic | 295 | 469 | 69 | $4,629 |
| Ztlido Lidocaine | 245 | 250 | 68 | $87K |
| Celecoxib Generic | 234 | 249 | 83 | $6,521 |
| Baclofen Generic | 211 | 327 | 50 | $3,809 |
| Lidocaine Generic | 191 | 194 | 42 | $15K |
| Clonazepam Generic | 190 | 190 | 24 | $1,109 |
| Clopidogrel Clopidogrel Bisulfate | 162 | 309 | 47 | $1,793 |
| Horizant Gabapentin Enacarbil | 143 | 167 | 26 | $108K |
| Namzaric Memantine Hcl/Donepezil Hcl | 127 | 261 | 30 | $153K |
| Cilostazol Generic | 118 | 214 | 24 | $2,622 |
Brand drugs: 2,075 claims; generic drugs: 6,769 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nagesh B Krish $8,398 ($8,398 in general payments such as food, travel and fees) from 47 companies. The largest payer was Abbvie Inc. with $1,024.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 38 | $1,024 |
| Axsome Therapeutics, Inc. AXSM | 22 | $963 |
| Lundbeck LLC | 16 | $613 |
| Biogen, Inc. BIIB | 8 | $539 |
| Amneal Pharmaceuticals LLC AMRX | 13 | $537 |
| Pfizer Inc. PFE | 25 | $474 |
| TG Therapeutics, Inc. TGTX | 5 | $330 |
| Alexion Pharmaceuticals, Inc. AZN | 7 | $329 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $311 |
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $240 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.